Immunitybio Inc IBRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 12:26 PM EDT

7.77

-0.33 (-4.07%)

Volume

1,917,130

52 week range

1.25 - 10.53

Open8.06
Day High8.16
Day Low7.73
Prev Close8.10
52 Week High10.53
52 Week High Date04/29/24
52 Week Low1.25
52 Week Low Date10/19/23

Key Stats

Market Cap5.373B
Shares Out691.57M
10 Day Average Volume7.65M
Dividend-
Dividend Yield-
Beta0.94
YTD % Change55.88

KEY STATS

Open8.06
Day High8.16
Day Low7.73
Prev Close8.10
52 Week High10.53
52 Week High Date04/29/24
52 Week Low1.25
52 Week Low Date10/19/23
Market Cap5.373B
Shares Out691.57M
10 Day Average Volume7.65M
Dividend-
Dividend Yield-
Beta0.94
YTD % Change55.88

RATIOS/PROFITABILITY

EPS (TTM)-1.05
P/E (TTM)-7.37
Fwd P/E (NTM)-12.14
EBITDA (TTM)-326.025M
ROE (TTM)-3,787.09%
Revenue (TTM)301,999.986
Gross Margin (TTM)-
Net Margin (TTM)-199,138.70%
Debt To Equity (MRQ)-122.99%

EVENTS

Earnings Date08/06/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Immunitybio Inc

Lightning Round: Diamondback Energy isn't good, it's great, says Jim CramerApril 26, 2024CNBC.com

Content From Our Affiliates

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Idexx Laboratories (IDXX) and ImmunityBio (IBRX)May 6, 2024TipRanks
ImmunityBio, Serm Institute of India enter BCG supply arrangementMay 2, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Healthcare Services (HCSG) and ImmunityBio (IBRX)April 29, 2024TipRanks
ImmunityBio (IBRX) Gets a Hold from Piper SandlerApril 29, 2024TipRanks
Largest borrow rate increases among liquid namesApril 25, 2024TipRanks

Profile

Immunitybio, Inc. is a vertically integrated, clinical-stage biotechnology company developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Using its proprietary platforms that amplify both the innate and adaptive branches of the immune system, its advances therapies and vaccines to defeat urologic and other cancers, as well as infectious diseases. Its platforms and their associated product candidates are designed to...

Patrick Soon-Shiong M.D.

Executive Chairman of the Board, Global Chief Scientific and Medical Officer

Richard Adcock

President, Chief Executive Officer, Director

Lennie Sender

Chief Operating Officer

David Sachs

Chief Financial Officer

Enrique Dilone Ph.D.

Chief Technology Officer

Address

3530 JOHN HOPKINS COURT

San Diego, CA

92121

United States

https://immunitybio.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
RVMD Revolution Medicines Inc	39.48	+0.09	+0.23%
CYTK Cytokinetics Inc	60.25	-0.25	-0.41%
BBIO BridgeBio Pharma Inc	30.83	+0.86	+2.87%
MDGL Madrigal Pharmaceuticals Inc	214.68	+2.95	+1.39%
NUVL Nuvalent Inc	74.21	+2.53	+3.53%